Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LEUKEMIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | LEUKEMIA |
| Key Genes/Proteins | ABL1, AKT, BAX, BCL2, BRAF, C1Q |
| Related Diseases | CANCER, CARCINOMA, CHEMORESISTANCE |
graph TD
LEUKEMIA["LEUKEMIA"]
LEUKEMIA -->|"activates"| Epigenetic["Epigenetic"]
LEUKEMIA -->|"activates"| Wnt["Wnt"]
LEUKEMIA -->|"activates"| Hedgehog["Hedgehog"]
LEUKEMIA -->|"activates"| Tgf__["Tgf-Beta"]
LEUKEMIA -->|"inhibits"| Notch["Notch"]
LEUKEMIA -->|"activates"| Immune_Response["Immune Response"]
LEUKEMIA -->|"activates"| Apoptosis["Apoptosis"]
JUN["JUN"] -->|"activates"| LEUKEMIA
XPO1["XPO1"] -->|"expressed in"| LEUKEMIA
NPM1["NPM1"] -.biomarker for.-> LEUKEMIA
MCL1["MCL1"] -->|"inhibits"| LEUKEMIA
BCL2["BCL2"] -->|"inhibits"| LEUKEMIA
BCL2L1["BCL2L1"] -->|"inhibits"| LEUKEMIA
LIF["LIF"] -->|"inhibits"| LEUKEMIA
EGFR["EGFR"] -->|"activates"| LEUKEMIA| Target | Relation | Type | Str |
|---|---|---|---|
| Apoptosis | activates | pathway | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Stem Cell | therapeutic_target | pathway | 1.00 |
| Drug Resistance | therapeutic_target | pathway | 1.00 |
| Nf-Κb | therapeutic_target | pathway | 0.90 |
| Pi3K/Akt | therapeutic_target | pathway | 0.90 |
| Apoptosis | inhibits | pathway | 0.90 |
| Cancer | activates | disease | 0.85 |
| Cancer | therapeutic_target | disease | 0.85 |
| Cell Cycle | therapeutic_target | pathway | 0.80 |
| Notch | therapeutic_target | pathway | 0.80 |
| Car-T | therapeutic_target | pathway | 0.80 |
| Metastasis | therapeutic_target | pathway | 0.80 |
| Nf-Κb | activates | pathway | 0.80 |
| Cancer | associated_with | disease | 0.75 |
| Als | expressed_in | disease | 0.75 |
| Lymphoma | inhibits | disease | 0.75 |
| Invasion | therapeutic_target | pathway | 0.70 |
| Multidrug Resistance | therapeutic_target | pathway | 0.70 |
| Oxidative Phosphorylation | therapeutic_target | pathway | 0.70 |
| Differentiation | therapeutic_target | pathway | 0.70 |
| Pi3K/Akt | inhibits | pathway | 0.70 |
| Jak-Stat | therapeutic_target | pathway | 0.70 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.70 |
| Autophagy | therapeutic_target | pathway | 0.70 |
| Chemoresistance | therapeutic_target | pathway | 0.70 |
| Drug Resistance | inhibits | pathway | 0.70 |
| Differentiation | activates | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Stem Cell | activates | pathway | 0.70 |
| Angiogenesis | therapeutic_target | pathway | 0.70 |
| Mtor | regulates | pathway | 0.70 |
| Angiogenesis | inhibits | pathway | 0.70 |
| Als | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Lung Cancer | associated_with | disease | 0.65 |
| Breast Cancer | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Lung Cancer | activates | disease | 0.65 |
| AKT | exacerbates | gene | 0.65 |
| CANCER | targets | disease | 0.65 |
| CHEMORESISTANCE | interacts_with | phenotype | 0.65 |
| Breast Cancer | activates | disease | 0.65 |
| Myelodysplastic Syndrome | associated_with | disease | 0.65 |
| OXIDATIVE PHOSPHORYLATION | targets | phenotype | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | therapeutic_target | gene | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| BCL2 | inhibits | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| BCL2 | therapeutic_target | gene | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| BCL-2 | therapeutic_target | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| NF-ΚB | therapeutic_target | gene | 0.95 |
| TP53 | therapeutic_target | gene | 0.95 |
| APOPTOSIS | inhibits | gene | 0.95 |
| AKT | inhibits | gene | 0.95 |
| CHIP | risk_factor_for | disease | 0.90 |
| Tumor | inhibits | disease | 0.85 |
| MYC | activates | gene | 0.85 |
| NUCLEAR JAK | contributes_to | protein | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| CAR T Cell Therapy | treats | cell_type | 0.85 |
| GENES | activates | gene | 0.85 |
| PI3K | regulates | gene | 0.85 |
| STAT3 | activates | gene | 0.85 |
| PI3K | inhibits | gene | 0.85 |
| NF-ΚB | activates | gene | 0.85 |
| OVERVIEW | therapeutic_target | gene | 0.85 |
| CANCER | expressed_in | gene | 0.85 |
| DNMT3A | associated_with | gene | 0.80 |
| LRP1 | targets | protein | 0.80 |
| ERK | therapeutic_target | gene | 0.75 |
| TP53 | inhibits | gene | 0.75 |
| GENES | inhibits | gene | 0.75 |
| GAIN | therapeutic_target | gene | 0.75 |
| NATURAL COMPOUNDS | therapeutic_target | gene | 0.75 |
| CYTOKINES | inhibits | gene | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| CANCER | biomarker_for | gene | 0.75 |
| EGFR | activates | gene | 0.75 |
| MITOCHONDRIA | therapeutic_target | gene | 0.75 |
| BAX | therapeutic_target | gene | 0.75 |
| MYC | therapeutic_target | gene | 0.75 |
| CD33 | therapeutic_target | gene | 0.75 |
| BCL2 | activates | gene | 0.75 |
| AUTOPHAGY | activates | gene | 0.75 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning LEUKEMIA in their description or question text
No additional research found